Product Images Ramipril

The given text suggests a graph or chart showing the proportion of patients under a placebo treatment and those receiving Ramipril, with follow-up lasting for several days. The y-axis possibly represents the proportion of patients and the x-axis indicates the number of follow-up days. The graph shows a significant difference between the two groups of patients, with Ramipril receiving an almost negligible proportion, compared to the placebo group. There is also a note highlighting a p-value of 0.0001.*

The given text provides data on incidence of composite outcome based on various groups such as cardiovascular disease, diabetes, age, sex, hypertension, coronary artery disease, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The number of patients in the placebo group is also mentioned in each category. However, the meaning and context of the numbers in the last line are not available as the has not recognized those characters.*

The text corresponds to the packaging of Ramipril, a medication with a strength of 16 mg and 30 capsules per container. The product reference number is 6112-0. The container indicates that it should be stored at 17 degrees Celsius.*